ATE495667T1 - Zusammensetzungen und verfahren für die verlängerung der überlebensdauer von blutplättchen - Google Patents

Zusammensetzungen und verfahren für die verlängerung der überlebensdauer von blutplättchen

Info

Publication number
ATE495667T1
ATE495667T1 AT05811897T AT05811897T ATE495667T1 AT E495667 T1 ATE495667 T1 AT E495667T1 AT 05811897 T AT05811897 T AT 05811897T AT 05811897 T AT05811897 T AT 05811897T AT E495667 T1 ATE495667 T1 AT E495667T1
Authority
AT
Austria
Prior art keywords
methods
compositions
platelet survival
extending
platelets
Prior art date
Application number
AT05811897T
Other languages
English (en)
Inventor
Keith Rosiello
Clausen Henrik
Hans Wandall
Thomas P Stossel
John Hartwig
Karin Hoffmeister
Original Assignee
Velico Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Velico Medical Inc filed Critical Velico Medical Inc
Application granted granted Critical
Publication of ATE495667T1 publication Critical patent/ATE495667T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/19—Platelets; Megacaryocytes
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0644—Platelets; Megakaryocytes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Developmental Biology & Embryology (AREA)
  • Epidemiology (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
AT05811897T 2004-10-15 2005-10-17 Zusammensetzungen und verfahren für die verlängerung der überlebensdauer von blutplättchen ATE495667T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61917604P 2004-10-15 2004-10-15
PCT/US2005/037241 WO2006044790A2 (en) 2004-10-15 2005-10-17 Compositions and methods for prolonging survival of platelets

Publications (1)

Publication Number Publication Date
ATE495667T1 true ATE495667T1 (de) 2011-02-15

Family

ID=36203621

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05811897T ATE495667T1 (de) 2004-10-15 2005-10-17 Zusammensetzungen und verfahren für die verlängerung der überlebensdauer von blutplättchen

Country Status (9)

Country Link
US (2) US8221745B2 (de)
EP (1) EP1812014B1 (de)
JP (1) JP5123663B2 (de)
AT (1) ATE495667T1 (de)
AU (1) AU2005295467B2 (de)
CA (1) CA2626363A1 (de)
DE (1) DE602005026043D1 (de)
ES (1) ES2363700T3 (de)
WO (1) WO2006044790A2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1796457B1 (de) 2004-09-07 2011-11-23 Velico Medical, Inc. Apparat zur verlängerung der überlebensdauer von blutplättchen
JP5552231B2 (ja) * 2005-10-14 2014-07-16 ベリコ メディカル インコーポレイティッド 血小板の生存延長のための組成物および方法
US8067151B2 (en) 2007-02-09 2011-11-29 Canadian Blood Services Cold storage of pegylated platelets at about or below 0° C.
US7964339B2 (en) 2007-02-09 2011-06-21 Canadian Blood Services Cold storage of modified platelets
US8835104B2 (en) 2007-12-20 2014-09-16 Fenwal, Inc. Medium and methods for the storage of platelets
EP2163261A1 (de) 2008-07-14 2010-03-17 Canadian Blood Services Kaltlagerung von PEG-modifizierten Blutplättchen
EP2211046B1 (de) * 2008-12-29 2011-03-02 C.R.F. Società Consortile per Azioni Brennstoffeinspritzsystem mit hoher Betriebswiederholbarkeit und -stabilität für einen Verbrennungsmotor
US8834402B2 (en) 2009-03-12 2014-09-16 Haemonetics Corporation System and method for the re-anticoagulation of platelet rich plasma
US8808978B2 (en) 2010-11-05 2014-08-19 Haemonetics Corporation System and method for automated platelet wash
US9302042B2 (en) 2010-12-30 2016-04-05 Haemonetics Corporation System and method for collecting platelets and anticipating plasma return
WO2012125955A2 (en) 2011-03-16 2012-09-20 Mayo Foundation For Medical Education And Research Methods and materials for prolonging useful storage of red blood cell preparations and platelet preparations
EP3662750A1 (de) 2011-04-07 2020-06-10 Fenwal, Inc. Automatisierte verfahren und systeme zur bereitstellung von thrombozytenkonzentraten mit reduziertem restplasmavolumen und medien zur lagerung solcher thrombozytenkonzentrate
US9788539B2 (en) 2011-05-17 2017-10-17 Velico Medical, Inc. Platelet protection solution having beta-galactosidase and sialidase inhibitors
US20120321722A1 (en) * 2011-05-17 2012-12-20 Qiyong Peter Liu Platelet Storage and Reduced Bacterial Proliferation In Platelet Products Using A Sialidase Inhibitor
WO2012158983A2 (en) * 2011-05-17 2012-11-22 Qiyong Peter Liu Improved platelet storage using a sialidase inhibitor
EP2903430A1 (de) 2012-10-05 2015-08-12 Velico Medical, Inc. Plättchenadditivlösung mit beta-galactosidase-inhibitor
JP6875619B2 (ja) * 2015-02-26 2021-05-26 株式会社細胞応用技術研究所 多血小板血漿の保存方法
US10897891B2 (en) 2015-04-10 2021-01-26 Board Of Regents, The University Of Texas System Compositions and methods for prolonged cell storage
US11197893B2 (en) * 2016-11-08 2021-12-14 Universidad De Caldas Pure platelet-rich plasma (P-PRP) composition for treatment of subclinical mastitis and methods of producing and using the same

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4344936A (en) * 1980-09-17 1982-08-17 Gerald Soslau Platelet composition having improved storage stability and method therefor
US4407660A (en) 1981-09-08 1983-10-04 Baxter Travenol Laboratories, Inc. Plasmapheresis assembly and associated fluid manifold
US4432750A (en) 1981-12-02 1984-02-21 Baxter Travenol Laboratories, Inc. Additive sterol solution and method for preserving normal red cell morphology in whole blood during storage
US4467588A (en) 1982-04-06 1984-08-28 Baxter Travenol Laboratories, Inc. Separated packaging and sterile processing for liquid-powder mixing
US4701267B1 (en) 1984-03-15 1996-03-12 Asahi Medical Co Method for removing leukocytes
US4610684A (en) 1984-06-22 1986-09-09 Abbott Laboratories Flexible container and mixing system for storing and preparing I.V. fluids
US4994039A (en) 1985-11-15 1991-02-19 Mattson Philip D Apparatus and method for patients from a single donor or a restricted group of donors
US4915848A (en) 1986-04-21 1990-04-10 Miles Laboratories, Inc. Red blood cell filtering system
US5344561A (en) 1989-05-09 1994-09-06 Pall Corporation Device for depletion of the leucocyte content of blood and blood components
US5910252A (en) 1993-02-12 1999-06-08 Cobe Laboratories, Inc. Technique for extracorporeal treatment of blood
JPH0967270A (ja) * 1995-08-31 1997-03-11 Res Dev Corp Of Japan 水晶体混濁の予防および治療法、並びにそのための薬 剤
CA2255121A1 (en) 1997-03-17 1998-09-24 Baxter International Inc. Red blood cell compositions and methods for collecting and storing red blood cells
US7018985B1 (en) 2000-08-21 2006-03-28 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
AU2002330968B2 (en) * 2001-08-17 2007-03-22 Neose Technologies, Inc. Chemo-enzymatic synthesis of sialylated oligosaccharides
ES2411007T3 (es) 2001-10-10 2013-07-04 Novo Nordisk A/S Remodelación y glicoconjugación de péptidos
US7264608B2 (en) 2001-12-05 2007-09-04 Fenwal, Inc. Manual processing systems and methods for providing blood components conditioned for pathogen inactivation
US7037428B1 (en) 2002-04-19 2006-05-02 Mission Medical, Inc. Integrated automatic blood processing unit
DK1503788T3 (da) * 2002-04-25 2011-10-17 Shire Human Genetic Therapies Behandling af alpha-galactosidase A-deficiens
EP1543106B1 (de) 2002-07-15 2007-04-11 Immunex Corporation Verfahren und medien zur kontrolle der sialysierung von proteinen, die von säugetierzellen produziert werden
WO2004043381A2 (en) * 2002-11-08 2004-05-27 The Brigham And Women's Hospital, Inc. Compositions and methods for prolonging survival of platelets
AU2004235777B9 (en) 2003-05-01 2009-02-05 Thermics Corporation Method and system for warming a fluid
EP1796457B1 (de) * 2004-09-07 2011-11-23 Velico Medical, Inc. Apparat zur verlängerung der überlebensdauer von blutplättchen
JP5552231B2 (ja) * 2005-10-14 2014-07-16 ベリコ メディカル インコーポレイティッド 血小板の生存延長のための組成物および方法

Also Published As

Publication number Publication date
JP5123663B2 (ja) 2013-01-23
AU2005295467B2 (en) 2011-07-07
EP1812014A4 (de) 2008-04-16
ES2363700T3 (es) 2011-08-12
JP2008516980A (ja) 2008-05-22
EP1812014B1 (de) 2011-01-19
US20130059287A1 (en) 2013-03-07
US8221745B2 (en) 2012-07-17
US20090155763A1 (en) 2009-06-18
EP1812014A2 (de) 2007-08-01
WO2006044790A3 (en) 2006-06-15
WO2006044790A2 (en) 2006-04-27
CA2626363A1 (en) 2006-04-27
DE602005026043D1 (de) 2011-03-03
AU2005295467A1 (en) 2006-04-27

Similar Documents

Publication Publication Date Title
ATE495667T1 (de) Zusammensetzungen und verfahren für die verlängerung der überlebensdauer von blutplättchen
ATE534290T1 (de) Apparat zur verlängerung der überlebensdauer von blutplättchen
WO2004043381A3 (en) Compositions and methods for prolonging survival of platelets
WO2007047687A3 (en) Compositions and methods for prolonging survival of platelets
EA200800240A1 (ru) Производные тиазола в качестве активатора амфк
TW200607506A (en) Tetrahydronaphthyridine derivatives
UA94417C2 (ru) Замещенные 7-азаиндазолы, композиция, которая их содержит, и применение
MXPA05009015A (es) Nuevos derivados de bencimidazol e imidazo-piridina y su utilizacion como medicamentos.
NO20090175L (no) Stabile laquinimod sammensetninger
ECSP088136A (es) Derivados de ciclohexilaminisoquinolona en calidad de inhibidores de rho-quinasa
EA200970156A1 (ru) Пиридизиноновые производные
EA202091230A3 (ru) Антагонисты активин-actrii и их применения для повышения уровней эритроцитов
TW200607494A (en) 3- or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands
ATE433447T1 (de) Pyrimiidinverbindungen
MX2009000285A (es) Piperidinas sustituidas que incrementan la actividad de p53 y usos de las mismas.
PA8719401A1 (es) Compuestos de tetrahidropiridotienopirimidina y metodos para su empleo
EA200971140A1 (ru) Триарильные соединения и композиции, их содержащие
EA200900337A1 (ru) Сульфонамидные производные в качестве адренергических агонистов и мускариновых антагонистов
AR055613A1 (es) Formas cristalinas delta y epsilon de mesilato de imatinib
EA200700601A1 (ru) Производные фениламинопиримидина как ингибиторы bcr-abl
MA32776B1 (fr) Inhibiteurs de l'akt et de la p70 s6 kinase
ECSP088252A (es) 7-aza-indazoles sustituidos, composiciones que los contienen, procedimiento de fabricación y utilización
ECSP067099A (es) Compuestos y métodos para inhibir la interacción de las proteínas bcl con los componentes de enlace
GT201300096A (es) Composiciones farmaceuticas que contienen un inhibidor de dgat1
EA200702329A1 (ru) Замещенные пирролпиридины, содержащие их композиции, способ получения и применение

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties